Imagine a disease in which a part of your immune system runs wild, destroying red blood cells and causing blood clots, strokes and, often, death within a few years. Now imagine a treatment that can curb that runaway process, saving the red blood cells and therefore the patient. And try imagining lots of people in New Haven finding work—helping to create or market treatments like that one.
